{"id":"W4310161323","doi":"10.1182/blood-2022-168140","title":"A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier de l’Université de Montréal; Spinal Cord Injury BC; University of British Columbia; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Toxicity; Oncology; Lymphoma; Adverse effect; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001143687,0.001971653,0.001283025,0.0004351902,0.000604937,0.001323665,0.001170183,0.001590805,0.005964183],"category_scores_gemma":[0.0006821257,0.000606245,0.0007185737,0.0003236638,0.001276126,0.001364153,0.0004652539,0.003920838,0.001316745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001118339,"about_ca_system_score_gemma":0.001788937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005903564,"about_ca_topic_score_gemma":0.001541301,"domain_scores_codex":[0.9996564,0.00009984043,0.00001498875,0.00008918769,0.00003284153,0.0001066863],"domain_scores_gemma":[0.9992355,0.00009581322,0.0001247898,0.00007489903,0.00004111003,0.0004278405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5141533,0.1764363,0.006646011,0.001213726,0.0008930333,0.0006285119,0.0007148593,0.003763256,0.107336,0.001174247,0.01300388,0.1740368],"study_design_scores_gemma":[0.3869066,0.5814902,0.007946003,0.00004086427,0.0002244948,0.0006469272,0.0001042744,0.001884187,0.0104017,0.0006645338,0.00964918,0.00004096971],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843969,0.001600344,0.001561503,0.0008259256,0.0001815625,0.005346703,0.002147758,0.0003581769,0.003581198],"genre_scores_gemma":[0.9791601,0.001330456,0.003126578,0.001671865,0.0001968471,0.003861782,0.003454034,0.00008633272,0.007112038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005964183,"threshold_uncertainty_score":0.01995218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03660661734123606,"score_gpt":0.3044627311404808,"score_spread":0.2678561137992447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}